<SEC-DOCUMENT>0000919574-14-002070.txt : 20140304
<SEC-HEADER>0000919574-14-002070.hdr.sgml : 20140304
<ACCEPTANCE-DATETIME>20140304151623
ACCESSION NUMBER:		0000919574-14-002070
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20140205
FILED AS OF DATE:		20140304
DATE AS OF CHANGE:		20140304

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MELA SCIENCES, INC. /NY
		CENTRAL INDEX KEY:			0001051514
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				133986004
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		50 SOUTH BUCKHOUT STREET
		STREET 2:		SUITE 1
		CITY:			IRVINGTON
		STATE:			NY
		ZIP:			10533
		BUSINESS PHONE:		914-591-3783

	MAIL ADDRESS:	
		STREET 1:		50 SOUTH BUCKHOUT STREET
		STREET 2:		SUITE 1
		CITY:			IRVINGTON
		STATE:			NY
		ZIP:			10533

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ELECTRO OPTICAL SCIENCES INC /NY
		DATE OF NAME CHANGE:	19971216

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			KOTLER KEVIN
		CENTRAL INDEX KEY:			0001601692

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51481
		FILM NUMBER:		14664301

	MAIL ADDRESS:	
		STREET 1:		C/O BROADFIN CAPITAL, LLC
		STREET 2:		237 PARK AVENUE, SUITE 900
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Broadfin Capital, LLC
		CENTRAL INDEX KEY:			0001511901
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51481
		FILM NUMBER:		14664302

	BUSINESS ADDRESS:	
		STREET 1:		237 PARK AVENUE, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		212-808-2463

	MAIL ADDRESS:	
		STREET 1:		237 PARK AVENUE, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Broadfin Healthcare Master Fund Ltd
		CENTRAL INDEX KEY:			0001511900
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51481
		FILM NUMBER:		14664303

	BUSINESS ADDRESS:	
		STREET 1:		C/O 20 GENESIS CLOSE
		STREET 2:		ANSBACHER HOUSE, SECOND FLOOR, 1344
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1108
		BUSINESS PHONE:		212-808-2460

	MAIL ADDRESS:	
		STREET 1:		C/O 20 GENESIS CLOSE
		STREET 2:		ANSBACHER HOUSE, SECOND FLOOR, 1344
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1108
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>p1457276.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2014-02-05</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001051514</issuerCik>
        <issuerName>MELA SCIENCES, INC. /NY</issuerName>
        <issuerTradingSymbol>MELA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001511900</rptOwnerCik>
            <rptOwnerName>Broadfin Healthcare Master Fund Ltd</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O 20 GENESIS CLOSE</rptOwnerStreet1>
            <rptOwnerStreet2>ANSBACHER HOUSE, SECOND FLOOR, 1344</rptOwnerStreet2>
            <rptOwnerCity>GRAND CAYMAN</rptOwnerCity>
            <rptOwnerState>E9</rptOwnerState>
            <rptOwnerZipCode>KY1-1108</rptOwnerZipCode>
            <rptOwnerStateDescription>CAYMAN ISLANDS</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001511901</rptOwnerCik>
            <rptOwnerName>Broadfin Capital, LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>237 PARK AVENUE, 9TH FLOOR</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001601692</rptOwnerCik>
            <rptOwnerName>KOTLER KEVIN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O BROADFIN CAPITAL, LLC</rptOwnerStreet1>
            <rptOwnerStreet2>237 PARK AVENUE, SUITE 900</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series A Convertible Preferred Stock, $0.10 per share</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.84</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2014-02-05</value>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F7"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, $0.001 par value per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4761905</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F4"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series A Convertible Preferred Stock, $0.10 per share</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.84</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2014-02-05</value>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F7"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, $0.001 par value per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4761905</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>Footnote</value>
                    <footnoteId id="F6"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Common Stock Warrant</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.74</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2014-02-05</value>
            </exerciseDate>
            <expirationDate>
                <value>2019-02-05</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, $0.001 par value per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4324324</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F5"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Common Stock Warrant</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.74</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2014-02-05</value>
            </exerciseDate>
            <expirationDate>
                <value>2019-02-05</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, $0.001 par value per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4324324</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>Footnote</value>
                    <footnoteId id="F6"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On February 5, 2014, pursuant to the terms of a securities purchase agreement, dated as of January 31, 2014, Broadfin Capital, LLC was sold (i) 4,000 shares of Series A Convertible Preferred Stock, which may be converted to 4,761,901 shares of common stock of the Issuer, and (ii) a Warrant, which may be exercised for 4,324,324 shares of common stock of the Issuer. The Series A Convertible Preferred Stock and the Warrant are held in the account of Broadfin Healthcare Master Fund, Ltd.</footnote>
        <footnote id="F2">In connection with this securities purchase agreement, Broadfin Capital, LLC shall not have the right to convert any portion of the Series A Convertible Preferred Stock or exercise the Warrant to purchase shares of common stock, to the extent that, after giving effect to the conversion or exercise, Broadfin Capital, LLC (directly or indirectly) would beneficially own in excess of 9.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of the Series A Convertible Preferred Stock or the exercise of the Warrant held by Broadfin Capital, LLC.</footnote>
        <footnote id="F3">In connection with Broadfin Capital, LLC's investment in the securities pursuant to the securities purchase agreement described above, Broadfin Capital, LLC has been granted the right to designate one director to the Board of Directors of the Issuer, so long as Broadfin Capital, LLC retains 30% of their investment in the Series A Preferred Stock or holds any warrants.</footnote>
        <footnote id="F4">The Series A Convertible Preferred Stock are held in the account of Broadfin Healthcare Master Fund, Ltd.</footnote>
        <footnote id="F5">The Warrant is held in the account of Broadfin Healthcare Master Fund, Ltd.</footnote>
        <footnote id="F6">The securities are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a &quot;group&quot; for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.</footnote>
        <footnote id="F7">None.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>BROADFIN HEALTHCARE MASTER FUND, LTD. By: /s/ Kevin Kotler, Director</signatureName>
        <signatureDate>2014-03-04</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>BROADFIN CAPITAL, LLC By: /s/ Kevin Kotler, Managing Member</signatureName>
        <signatureDate>2014-03-04</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Kevin Kotler</signatureName>
        <signatureDate>2014-03-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
